October 1, 1997Journal of Interventional Cardiology
The Total Artificial Heart: From Initial Application to Therapeutic Option
Key result
Total artificial heart implantation as a bridge to transplantation resulted in 67% of implanted patients and 94% of transplanted patients being discharged alive in the most recent series.
Why the study?
Does total artificial heart (TAH) implantation provide a viable bridge to transplantation in selected patients?
Population
311 patients worldwide who received total artificial heart implantation over 27 years.
Design
Review
Follow-up
average support time 24 to 30 days
Authors
Discussion
Loading...
Member takes
Implication
Supports TAH as bridge in selected patients; leaves open need for prospective trials to confirm viability.
Structured PICO
Does total artificial heart (TAH) implantation provide a viable bridge to transplantation in selected patients?
P
Population
Review of worldwide clinical experience with total artificial heart implantation in 311 patients with heart failure, primarily as a bridge to transplantation.
I
Intervention
Total artificial heart (TAH) implantation (8 different pneumatically driven devices, predominantly Utah-developed).
O
Outcome
Survival to hospital discharge and average support time.hard clinical
Total artificial heart implantation has evolved into a viable therapeutic option as a bridge to transplantation for selected patients inappropriate for LVADs, with improving survival and decreasing complication rates.
Cite This Study
Olsen et al. (1997) conducted a review in Heart failure (n=311). Total Artificial Heart (TAH) was evaluated on Survival to hospital discharge. Total artificial heart implantation as a bridge to transplantation resulted in 67% of implanted patients and 94% of transplanted patients being discharged alive in the most recent series.